AKT1 and neoplasm: They appear to have a biphasic effect on AKT, particularly at Thr308,49 but might also target PI3K and trigger feedback mechanisms involving tyrosine signaling.11, 32 Determination of tumor DGKζ levels might be a useful marker for therapy assignment and could improve interpretation of therapeutic effectiveness.